Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04510753 · ClinicalTrials.gov registry record

Data Collection of Arterial Line Waveform and BP Values

A clinical trial of Blood Pressure Measurement, sponsored by Sensifree.

Completed
Registry status
100
Enrollment target
1
Study location

NCT04510753: Completed study of Blood Pressure Measurement, sponsored by Sensifree.

NCT04510753 is a study of Blood Pressure Measurement that has completed, run by Sensifree. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04510753, a study of Blood Pressure Measurement, has completed, sponsored by Sensifree.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Collect continuous systolic and diastolic blood pressure values and waveforms as recorded by an arterial line catheter and by non-invasive blood pressure (NIBP) and to collect Photoplethysmogram Pulse Oximetry (PPG) waveform in order to optimize the Sensifree algorithm.

Primary Outcome

PPG signal will be acquired from the PPG sensor, while blood pressure values (systolic, diastolic, mean) will be acquired from A-line. PPG signal will be analyzed by the Sensifree's algorithm and compared to the A-line BP measurement results according to ISO 81060-2 accuracy specifications

Conditions Studied

Interventions

  • DEVICE Arterial catheterization kit
  • DEVICE GE Datex-Ohmeda Finger Clip Pulse Oximeter Sensor
  • DEVICE NIBP Cuff (GE Healthcare)

Study Locations (1)

California

  • San Francisco Veterans Affairs Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-11-22
Est. Completion 2020-12-09
Sensifree

3 total trials

What the finished NCT04510753 record still lists

NCT04510753 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Blood Pressure Measurement appearing as the primary indexed condition, and to 3 interventions - of which Arterial catheterization kit is the first listed.

NCT04510753 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04510753 about?

NCT04510753 is a clinical study titled "Data Collection of Arterial Line Waveform and BP Values". Collect continuous systolic and diastolic blood pressure values and waveforms as recorded by an arterial line catheter and by non-invasive blood pressure (NIBP) and to collect Photoplethysmogram Pulse Oximetry (PPG) waveform in order to optimize the Sensifree algorithm.

What is the current status of trial NCT04510753?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-11-22. Estimated completion is 2020-12-09.

What conditions does trial NCT04510753 study?

This clinical trial studies the following conditions: Blood Pressure Measurement.

What interventions are being tested in trial NCT04510753?

The interventions under investigation include: Arterial catheterization kit (DEVICE), GE Datex-Ohmeda Finger Clip Pulse Oximeter Sensor (DEVICE), NIBP Cuff (GE Healthcare) (DEVICE).

Who is sponsoring clinical trial NCT04510753?

This trial is sponsored by Sensifree, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04510753 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure Measurement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04510753, the US trial registry maintained by the National Library of Medicine. NCT04510753 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.